| Efficacy and safety of recombinant human activated protein C for severe sepsis. Bernard GR, Vincent JL, Laterre PF, Larosa SP, Dhainaut JF, López-Rodríguez ... N Eng J Med 344, 699-709, 2001 | 7687* | 2001 |
| Drotrecogin alfa (activated) in adults with septic shock Ranieri VM, Thompson BT, Baire PS, Dhainaut JF, Douglas IS, Finfer S ... N Eng J Med 366 (22), 2055-64, 2012 | 1563* | 2012 |
| Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain Ferrer R, Artigas A, Levy MM, Blanco J, González-Diaz G, Garnacho-Montero J ... JAMA 299, 2294-2303, 2008 | 973 | 2008 |
| Effectiveness of treatments for severe sepsis. A prospective, multicenter, observational study R. Ferrer, A. Artigas, D. Suarez, E. Palencia, ML. Levy, A. Arenzana, XL ... Am J Resp Crit Care Med 180, 861-866, 2009 | 572 | 2009 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 549 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 392 | 2021 |
| Impact of source control in patients with severe sepsis and septic shock Martínez ML, Ferrer R, Torrents E, Guillamat-Prats R, Gomà G, Suárez D ... Crit Care Med 45, 11-19, 2017 | 204 | 2017 |
| The 2013 Seville Consensus Document on alternatives to allogenic blood transfusion. An update on the Seville Document. Med Intensiva 37 (4), 259-283, 2013 | 180* | 2013 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 176 | 2022 |
| Spanish consensus statement on alternatives to allogeneic blood transfusion: the 2013 update of the “Seville Document Leal-Noval SR, Muñoz M, Asuero M, Contreras E, García-Erce JA, Llau JV ... Blood Transfus 11, 585-610, 2013 | 162* | 2013 |
| Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome L Chiscano-Camón, JC Ruiz-Rodriguez, A Ruiz-Sanmartin, O Roca, ... Critical care 24, 1-3, 2020 | 156 | 2020 |
| Innovative continuous non-invasive cuffless blood pressure monitoring based on photoplethysmography technology JC Ruiz-Rodríguez, A Ruiz-Sanmartín, V Ribas, J Caballero, ... Intensive care medicine 39, 1618-1625, 2013 | 138 | 2013 |
| Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock J. Gómez-Jiménez, M.C. Martín, R. Sauri, R.M. Segura, F. Esteban, J.C. Ruiz ... J Infect Dis 171, 472-475, 1995 | 132 | 1995 |
| Humidified High Flow Nasal Cannula Supportive Therapy Improves Outcomes in Lung Transplant Recipients Readmitted to the Intensive Care Unit Because of Acute Respiratory Failure Roca O, García de Acilu M, Caralt B, Sacanell S, Masclans JR, ICU collaborators Transplantation 99 (5), 1092-8, 2015 | 127 | 2015 |
| An approach to antibiotic treatment in patients with sepsis ML Martínez, EP Plata-Menchaca, JC Ruiz-Rodríguez, R Ferrer Journal of thoracic disease 12 (3), 1007, 2020 | 113 | 2020 |
| Epidemiology of sepsis in Catalonia: analysis of incidence and outcomes in a European setting JC Yébenes, JC Ruiz-Rodriguez, R Ferrer, M Clèries, A Bosch, ... Annals of intensive care 7, 1-10, 2017 | 108 | 2017 |
| Antibiotic prescription patterns in the empirical therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality Diaz-Martin A, Martinez-Gonzalez ML, Ferrer R, Ortiz-Leyba C, Piacentini E ... Crit Care 16, R223, 2012 | 107* | 2012 |
| Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients R Ferrer, X Mateu, E Maseda, JC Yébenes, C Aldecoa, C De Haro, ... Expert Review of Clinical Pharmacology., 2017 | 106 | 2017 |
| Cost-effectiveness of the Surviving Sepsis Campaign Protocol for Severe Sepsis in Spain: a prospective nation-wide study in Spain D Suarez, R Ferrer, A Artigas, I Azkarate, J Garnacho-Montero, G Gomà, ... Intensive Care Med 37, 444-452, 2010 | 105* | 2010 |
| Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study JC Ruiz-Rodríguez, J Caballero, A Ruiz-Sanmartin, VJ Ribas, M Pérez, ... Medicina Intensiva (English Edition) 36 (7), 475-480, 2012 | 104 | 2012 |
